82467-2
LaboratoryriTUXimab [Mass/volume] in Serum or Plasma by Immunoassay
Definition
This serum rituximab drug level is intended for quantitative measurements of rituximab levels in human serum to aid in patient-specific therapeutic drug monitoring and dosing for individuals with non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and rheumatoid arthritis.
LOINC 6-Axis Classification
Component
riTUXimab
Property
MCnc
Time Aspect
Pt
System
Ser/Plas
Scale Type
Qn
Method Type
IA
Details
Class
DRUG/TOX
Order/Observation
Both
Short Name
riTUXimab SerPl IA-mCnc
Display Name
riTUXimab IA [Mass/Vol]
Related Names
Frequently Asked Questions
What is LOINC code 82467-2?
LOINC code 82467-2 identifies "riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay". This serum rituximab drug level is intended for quantitative measurements of rituximab levels in human serum to aid in patient-specific therapeutic drug monitoring and dosing for individuals with non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and rheumatoid arthritis.
What does 82467-2 measure?
This code measures riTUXimab in Ser/Plas. It belongs to the DRUG/TOX class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.